ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I ANTI-HBS REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
|
Back to Search Results |
|
Catalog Number 07P89-74 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/05/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
This report is being filed on an international product, list number 07p89-74 and there is a similar product distributed in the us, list number 7p88.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Event Description
|
The customer reported false elevated alinity i anti-hbs and provided the following data: the anti-hbs result was 52.82 miu/ml and repeat was 49.84 miu/ml (reference: based on the world health organization recommendation, an antihbs concentration = 10 miu/ml is regarded as being protective) the customer tested the sample on the maccura platform, and the result was negative (no value provided); the colloidal gold result was negative.Additional laboratory information: hbsag/hbeag/anti-hbc were positive.The customer confirmed that they are not questioning any of the additional laboratory results.Patient information: 58 year-old man, clinically diagnosed with a remote rib fracture.Per the customer the discrepant results were not reported out to the patient¿s medical provider.There was no reported impact to patient management.There was no reported impact to patient management.
|
|
Manufacturer Narrative
|
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, trending review, labeling review, device history record review, and field data review.Return testing was not completed as returns were not yet available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Device history review for the complaint lot did not identify any non-conformances or deviations associated with the customer reported issue.Ticket search by lot did not identify an increase in complaint activity for the complaint lot.Trending review has not identified any trends.The overall performance of alinity i anti-hbs was reviewed using field data from customers.The review found that the patient median result is comparable with all other lots in the field and within established baselines, confirming no systemic issue.Labeling was reviewed and was found to address the customer reported issue.Based on the available information, no systemic issue or deficiency was identified for the alinity i anti-hbs reagent lot 51253fn01.
|
|
Event Description
|
The customer reported false elevated alinity i anti-hbs and provided the following data: the anti-hbs result was 52.82 miu/ml and repeat was 49.84 miu/ml (reference: based on the world health organization recommendation, an antihbs concentration = 10 miu/ml is regarded as being protective) the customer tested the sample on the maccura platform, and the result was negative (no value provided); the colloidal gold result was negative.Additional laboratory information: hbsag/hbeag/anti-hbc were positive.The customer confirmed that they are not questioning any of the additional laboratory results.Patient information: 58 year-old man, clinically diagnosed with a remote rib fracture.Per the customer the discrepant results were not reported out to the patient¿s medical provider.There was no reported impact to patient management.There was no reported impact to patient management.
|
|
Search Alerts/Recalls
|
|
|